3rd Annual Pharmaceutical Portfolio Strategy & Management ConferenceJuly 16-17, 2020 | Philadelphia, PA
Optimizing Portfolio Strategy & Management via Improved Project Prioritization with an Emphasis on Proactive Risk Identification & Mitigation, Ensuring Thorough Measurement of Individual Projects’ Probability of Success, all while Leveraging Data Analytics & Artificial Intelligence to Enhance Complex Decision-Making Processes
In the highly-competitive pharmaceutical marketplace, where the commercial success of the company depends on the strategic allocation of resources among projects in the pipeline, portfolio managers aim to continuously improve processes to ensure optimal decisions are made to efficiently prioritize efforts. Taking into account the uncertainty of the narrowing market, portfolio leaders recognize that effective prioritization must go beyond quantitative factors such as NPV and projected ROI, to also include qualitative elements such as the competitive landscape, timing, and complexity of clinical trials required, as well as considerations regarding the potential for geographic expansion and movement into new therapeutic areas. Taking into account all necessary considerations in the decision-making process remains the critical task of portfolio strategy and management professionals, in particular with respect to emerging technology and early-phase programs.
The 3rd edition of the Q1 Productions Pharmaceutical Portfolio Strategy & Management Conference will provide a platform for industry leaders to share successful methods for quantifying risk, practically address challenges presented by the narrowing marketplace, and shed light on existing and potential use of machine learning within pipeline decision-making. With an emphasis on the use of predictive analytics to determine clinical trial success and overall project viability, the conference will focus on the need to identify a range of possibilities when calculating the probability of success, rather than relying on limited data points potentially leading to inaccurate estimation of product ROI. Attendees are offered practical knowledge-share and the opportunity to compare strategies with other leaders in the industry, making the program a must-attend educational event.